Supernus Pharmaceuticals
Develops CNS medicines spanning ADHD, Parkinson’s disease, postpartum depression, and epilepsy.
$44.58
After-hours close+0.82 (+1.87%)
At close$43.76(−0.97%)
| Date | Estimate | Reported | Surprise |
|---|---|---|---|
| Nov 2026 | $0.62 | — | — |
| Aug 2026 | $0.42 | $0.54 | +27.8% |
| May 2026 | $0.28 | $0.59 | +110.7% |
| Feb 2026 | $0.28 | $0.92 | +228.6% |
| Nov 2025 | $0.82 | $1.01 | +23.2% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | |||
| Aug 2025 | |||
| May 2025 | |||
| Feb 2025 | |||
| Nov 2024 | |||
| Aug 2024 | |||
| May 2024 | |||
| Feb 2024 | |||
| Nov 2023 | |||
| Aug 2023 | |||
| May 2023 | |||
| Feb 2023 | |||
| Nov 2022 | |||
| Aug 2022 | |||
| Apr 2022 | |||
| Feb 2022 | |||
| Nov 2021 | |||
| Aug 2021 | |||
| May 2021 | |||
| Feb 2021 | |||
| Nov 2020 | |||
| Aug 2020 | |||
| May 2020 | |||
| Feb 2020 | |||
| Nov 2019 | |||
| Aug 2019 | |||
| May 2019 | |||
| Feb 2019 | |||
| Nov 2018 | |||
| Aug 2018 | |||
| May 2018 | |||
| Feb 2018 | |||
| Nov 2017 | |||
| Aug 2017 | |||
| May 2017 | |||
| Feb 2017 | |||
| Jan 2017 | |||
| Aug 2016 | |||
| May 2016 | |||
| Mar 2016 | |||
| Nov 2015 | |||
| Aug 2015 | |||
| Report date | EPS est | EPS | Surprise | Revenue est | Revenue | Surprise |
|---|---|---|---|---|---|---|
| Nov 3, 2026 | $0.62 | — | — | $218.3M | — | — |
| Aug 3, 2026 | $0.42 | $0.54 | +27.8% | $205.3M | $219.1M | +6.7% |
| May 5, 2026 | $0.28 | $0.59 | +110.7% | $192.9M | $207.7M | +7.7% |
| Feb 24, 2026 | $0.28 | $0.92 | +228.6% | $195.2M | $211.6M | +8.4% |
| Nov 4, 2025 | $0.82 | $1.01 | +23.2% | $194.7M | $192.1M | −1.3% |
The latest year is open to everyone — the 41 quarters behind it read with an account. Sign in | ||||||
| Aug 5, 2025 | ||||||
| May 6, 2025 | ||||||
| Feb 25, 2025 | ||||||
| Nov 4, 2024 | ||||||
| Aug 6, 2024 | ||||||
| May 8, 2024 | ||||||
| Feb 27, 2024 | ||||||
| Nov 8, 2023 | ||||||
| Aug 8, 2023 | ||||||
| May 9, 2023 | ||||||
| Feb 28, 2023 | ||||||
| Nov 8, 2022 | ||||||
| Aug 4, 2022 | ||||||
| Apr 13, 2022 | ||||||
| Feb 28, 2022 | ||||||
| Nov 3, 2021 | ||||||
| Aug 4, 2021 | ||||||
| May 5, 2021 | ||||||
| Feb 25, 2021 | ||||||
| Nov 3, 2020 | ||||||
| Aug 18, 2020 | ||||||
| May 5, 2020 | ||||||
| Feb 25, 2020 | ||||||
| Nov 5, 2019 | ||||||
| Aug 6, 2019 | ||||||
| May 7, 2019 | ||||||
| Feb 26, 2019 | ||||||
| Nov 6, 2018 | ||||||
| Aug 7, 2018 | ||||||
| May 8, 2018 | ||||||
| Feb 27, 2018 | ||||||
| Nov 6, 2017 | ||||||
| Aug 2, 2017 | ||||||
| May 9, 2017 | ||||||
| Feb 28, 2017 | ||||||
| Jan 20, 2017 | ||||||
| Aug 2, 2016 | ||||||
| May 3, 2016 | ||||||
| Mar 2, 2016 | ||||||
| Nov 3, 2015 | ||||||
| Aug 4, 2015 | ||||||